BlackRock’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,373
| Closed | -$9K | – | 5072 |
|
|
2019
Q4 | $9K | Sell |
17,373
-148,658
| -90% | -$77K | ﹤0.01% | 4690 |
|
|
2019
Q3 | $633K | Sell |
166,031
-1,533
| -0.9% | -$5.85K | ﹤0.01% | 4058 |
|
|
2019
Q2 | $1.11M | Sell |
167,564
-313,617
| -65% | -$2.08M | ﹤0.01% | 3919 |
|
|
2019
Q1 | $1.71M | Sell |
481,181
-25,266
| -5% | -$89.7K | ﹤0.01% | 3716 |
|
|
2018
Q4 | $2.01M | Buy |
506,447
+21,344
| +4% | +$84.6K | ﹤0.01% | 3631 |
|
|
2018
Q3 | $9.58M | Buy |
485,103
+153,448
| +46% | +$3.03M | ﹤0.01% | 3222 |
|
|
2018
Q2 | $10.5M | Buy |
331,655
+160,175
| +93% | +$5.09M | ﹤0.01% | 3187 |
|
|
2018
Q1 | $6.34M | Buy |
171,480
+50,589
| +42% | +$1.87M | ﹤0.01% | 3295 |
|
|
2017
Q4 | $9.55M | Buy |
+120,891
| New | +$9.55M | ﹤0.01% | 3136 |
|